DECREASED ACETYLATION OF ISONIAZID IN CHRONIC-RENAL-FAILURE

被引:53
作者
KIM, YG
SHIN, JG
SHIN, SG
JANG, IJ
KIM, SG
LEE, JS
HAN, JS
CHA, YN
机构
[1] SEOUL NATL UNIV,COLL MED,DEPT PHARMACOL,CLIN PHARMACOL UNIT,28 YEONGUNDONG,CHONGRO GU,SEOUL 110799,SOUTH KOREA
[2] SEOUL NATL UNIV,COLL MED,DEPT INTERNAL MED,SEOUL,SOUTH KOREA
[3] INHA UNIV,COLL MED,DEPT PHARMACOL,INCHON,PEOPLES R CHINA
关键词
D O I
10.1038/clpt.1993.198
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacokinetic parameters of isoniazid obtained from 37 normal subjects were compared with parameters obtained from 14 patients with chronic renal failure. In the 29 normal rapid acetylators and eight normal slow acetylators, the mean plasma half-life values of isoniazid were 1.54 +/- 0.31 and 3.68 +/-0.59 hours, respectively. The plasma half-life values of isoniazid in patients with chronic renal failure varied widely from 1.30 to 10.13 hours, but the values were significantly longer than those of normal subjects. Because isoniazid clearance is governed mainly by hepatic metabolism, such a significant prolongation of plasma half-life of isoniazid was unexpected; thus the pharmacokinetics of isoniazid were reevaluated in the same patients with chronic renal failure after the kidney transplantation. After successful kidney transplantation, the shortening of isoniazid half-life was pronounced and the nonrenal clearance was markedly increased. These findings indicate that decreased isoniazid clearance in chronic renal failure is caused in minor part by the decreased renal excretion of isoniazid and in major part by the depressed hepatic N-acetylation of isoniazid.
引用
收藏
页码:612 / 620
页数:9
相关论文
共 22 条
[1]  
BERKERSKY I, 1980, J PHARM SCI, V69, P1359
[2]  
BERMAN M, DHEW NIH78180 PUBL
[3]   IMMUNE POTENTIAL IN HUMAN UREMIA .1. RELATIONSHIP OF GLOMERULAR-FILTRATION RATE TO DEPRESSION OF IMMUNE POTENTIAL [J].
BYRON, PR ;
MALLICK, NP ;
TAYLOR, G .
JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (09) :765-769
[4]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[5]  
CUSS FMC, 1986, CLIN NEPHROL, V25, P129
[6]  
DETTLI L, 1973, 5 P INT C PHARM, V3, P165
[7]  
DEVADATTA S, 1960, Bull World Health Organ, V23, P587
[8]   PHARMACOKINETICS OF ISONIAZID METABOLISM IN MAN [J].
ELLARD, GA ;
GAMMON, PT .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (02) :83-113
[9]   KINETICS OF PROCAINAMIDE AND N-ACETYLPROCAINAMIDE IN RENAL-FAILURE [J].
GIBSON, TP ;
ATKINSON, AJ ;
MATUSIK, E ;
NELSON, LD ;
BRIGGS, WA .
KIDNEY INTERNATIONAL, 1977, 12 (06) :422-429
[10]   RENAL-DISEASE AND DRUG-METABOLISM - AN OVERVIEW [J].
GIBSON, TP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 8 (01) :7-17